Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Callan Jmb (CJMB) EBITDA (2024 - 2025)

Callan Jmb (CJMB) has disclosed EBITDA for 2 consecutive years, with -$1.9 million as the latest value for Q3 2025.

  • Quarterly EBITDA fell 140.61% to -$1.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$5.8 million through Sep 2025, changed N/A year-over-year, with the annual reading at -$2.3 million for FY2024, 203.3% down from the prior year.
  • EBITDA hit -$1.9 million in Q3 2025 for Callan Jmb, down from -$1.4 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$87459.0 in Q1 2024 to a low of -$1.9 million in Q3 2025.